Results
Sun Pharma Q1 FY27 Revenue Rises 10.1% YoY
Sun Pharma reported Q1 FY27 consolidated sales of INR 1,51,836 million, a 10.1% YoY growth, with an EBITDA of INR 44,177 million.
The company incurred INR 1,617 million in exceptional costs for the pe
